In-depth analysis of the safety of CAR-T cell therapy for solid tumors
In recent years, the rapid progress in oncology, immunology, and molecular biology has dramatically advanced cancer immunotherapy, particularly CAR-T cell therapy. This innovative approach involves engineering a patient’s T cells to express receptors that specifically target tumor antigens, enhancin...
Saved in:
| Main Authors: | Jiayi Dong, Jiexiong Wu, Ye Jin, Zhu Zheng, Ting Su, Lijuan Shao, Jiaxin Bei, Size Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1548979/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug functional remapping: a new promise for tumor immunotherapy
by: Jiayi Dong, et al.
Published: (2025-03-01) -
Cell-based immunotherapies for solid tumors: advances, challenges, and future directions
by: Ting Zhao, et al.
Published: (2025-04-01) -
CAR-armored-cell therapy in solid tumor treatment
by: Yan Liu, et al.
Published: (2024-11-01) -
Precision sniper for solid tumors: CAR-NK cell therapy
by: Sisi Li, et al.
Published: (2025-07-01) -
Effectiveness, Limitations, and Future Perspectives of CAR-T Cell Therapy in Solid Tumor Treatment: A Narrative Review
by: Dmytro Kowalczuk, et al.
Published: (2025-05-01)